Holen Sie sich die Stockscreener-App
2.67
10.33%
0.25
Handel nachbörslich:
2.65
-0.02
-0.75%
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - simplywall.st
Pacific Biosciences of California (NASDAQ:PACB) Trading Up 7.9%Still a Buy? - MarketBeat
Here's why you should add PacBio stock to your portfolio - MSN
Volume Summary: Does Erayak Power Solution Group Inc have high return on assetsJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Sumitomo Mitsui Trust Group Inc. Has $11.11 Million Position in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know - sharewise.com
Pacific Biosciences Shares Gain Momentum on Strong Preliminary Results and Clinical Adoption - AD HOC NEWS
Pacific Biosciences of California (NASDAQ:PACB) Shares Down 6.6%Time to Sell? - MarketBeat
Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 11% Over Last Week - 富途牛牛
PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Trading 6.2% HigherStill a Buy? - MarketBeat
Pacific Biosciences of California unveils HiFi sequencing demo at PAG33 - Traders Union
Canada Next-Generation Sequencing (NGS) Market Analysis and - GlobeNewswire
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - Yahoo Finance
Pacific Biosciences stock gets Buy rating reiteration from Canaccord By Investing.com - Investing.com Canada
Pacific Biosciences' Preliminary Q4 Revenue Climb 14% On DNA Sequencing System Sales - Nasdaq
PACB: Clinical adoption and SPRQ innovation drive growth, with Europe leading and costs dropping - TradingView — Track All Markets
PACB: Clinical growth, Spark Chemistry, and record consumables drive robust momentum into 2026 - TradingView — Track All Markets
PacBio plans collaboration on rare disease therapies with n-Lorem By Investing.com - Investing.com Canada
PacBio (PACB) Advances Childhood Death Research with HiFi Genome Sequencing - GuruFocus
PACB Forecasts Strong FY25 Revenue as Sales Gain Traction - GuruFocus
PacBio Announces Proposed Collaboration with n-Lorem Foundation and EspeRare to Advance Antisense Oligonucleotide Therapies for Rare Genetic Diseases - Quiver Quantitative
PacBio to Support Research on Sudden Unexplained Death in Childhood Using HiFi Whole-Genome Sequencing - Quiver Quantitative
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases - Sahm
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) - marketscreener.com
New DNA test seeks deeper answers for parents after child deaths - Stock Titan
New effort uses full genome scans to craft one-of-a-kind rare disease drugs - Stock Titan
Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN
How PacBio (PACB) Is Seeing Its Fair Value Story Shift After ARK’s Share Purchase - Yahoo Finance
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y - MSN
PacBio stock dips post latest launch to expand multiomics capabilities - MSN
HOKA Shopping Guide: Can Pacific Biosciences of California Inc. stock double in next 5 years - ulpravda.ru
PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities - sharewise.com
Can PacBio’s New CiFi Method Reshape PACB’s Innovation Story and Recurring Revenue Potential? - Yahoo Finance
Can Pacific Biosciences of California Inc. stock deliver consistent earnings growthOptions Play & Short-Term High Return Strategies - ulpravda.ru
What insider trading reveals about Pacific Biosciences of California Inc. stockTrade Exit Summary & Smart Investment Allocation Tips - Улправда
How Pacific Biosciences of California Inc. (P09) stock trades after rate cutsPortfolio Update Report & Reliable Entry Point Alerts - ulpravda.ru
Is Pacific Biosciences of California Inc. stock a defensive play in 20252025 Earnings Impact & Daily Growth Stock Investment Tips - Улправда
What technical charts say about Pacific Biosciences of California Inc. stockJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - ulpravda.ru
Can Pacific Biosciences of California Inc. stock double in next 5 yearsJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - ulpravda.ru
PacBio and UC Davis Researchers Introduce CiFi, A New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from A Single SMRT Cell - marketscreener.com
PacBio introduces CiFi method for chromosome-scale genome assembly By Investing.com - Investing.com Canada
PacBio Introduces CiFi: A Breakthrough Method for Chromosome-Scale Genome Assemblies from Limited Sample Material - Quiver Quantitative
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell - marketscreener.com
New DNA mapping method builds full chromosomes from tiny samples - Stock Titan
Will Pacific Biosciences of California Inc. (P09) stock justify high valuationFed Meeting & Expert Curated Trade Ideas - ulpravda.ru
Barclays analyst is bullish on Pacific Biosciences of California, Inc. (PACB) - MSN
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know - sharewise.com
Here's Why You Should Add PacBio Stock to Your Portfolio - Yahoo Finance
PACB (Pacific Biosciences of California) Land And Improveme - GuruFocus
What analysts say about Pacific Biosciences of California Inc stockOptions Trading Strategies & Low Entry Cost Trading - earlytimes.in
Three Genomics Stocks Worth Tracking This Year - Nasdaq
We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt - simplywall.st
What drives Pacific Biosciences of California Inc P09 stock priceMarket Volatility Update & Missed Nvidia? Don’t Miss This One - earlytimes.in
1.74%
1.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):